MSFP
IDXX icon

Mark Sheptoff Financial Planning’s Idexx Laboratories IDXX Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$27K – 403
2022
Q1 		$27K Hold
50
– – 0.01% 220
2021
Q4 		$33K Hold
50
– – 0.02% 214
2021
Q3 		$31K Hold
50
– – 0.02% 209
2021
Q2 		$32K Hold
50
– – 0.02% 230
2021
Q1 		$24K Hold
50
– – 0.01% 216
2020
Q4 		$25K Hold
50
– – 0.01% 200
2020
Q3 		$20K Hold
50
– – 0.01% 190
2020
Q2 		$17K Hold
50
– – 0.01% 210
2020
Q1 		$12K Buy
50
+25
+100% +$6.52K 0.01% 217
2019
Q4 		$7K Buy
+25
New +$6.59K ﹤0.01% 303

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Mark Sheptoff Financial Planning's IDXX Position: Q2 2022 in Review

Mark Sheptoff Financial Planning sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 50 shares — an estimated $27K sold.

Mark Sheptoff Financial Planning first reported a position in IDXX in Q4 2019 and held it in 10 quarters. The position peaked at $33K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Mark Sheptoff Financial Planning reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 50 Idexx Laboratories shares in Q2 2022, an estimated $27K.
  • Mark Sheptoff Financial Planning first reported a position in Idexx Laboratories in Q4 2019 and held it in 10 quarters.
  • Mark Sheptoff Financial Planning's Idexx Laboratories position peaked at $33K in Q4 2021.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Mark Sheptoff Financial Planning's 13F filing for Q2 2022, filed 11 Aug 2022.